NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET 2024-2032

As per Triton’s research, the North America artificial blood vessels market is estimated to progress at a CAGR of 5.98% during the forecast period 2024-2032.

Report scope can be customized per your requirements - Request Free Sample Report

The artificial blood vessels market in North America has seen significant growth, owing to advancements in biotechnology and increasing demand for vascular grafts in cardiovascular surgeries. The US and Canada have played a pivotal role in fostering innovation through funding and regulatory support. For instance, the US Food and Drug Administration (FDA) has been actively involved in facilitating the approval of new vascular grafts. It has implemented policies to streamline the process for companies developing synthetic blood vessels. Moreover, initiatives like the National Institutes of Health (NIH) grants for research into tissue engineering and vascular regeneration are bolstering the development of novel bioengineered vessels. These efforts aim to address the growing incidence of cardiovascular diseases, providing solutions for patients requiring bypass surgery or vascular replacement.

The countries mentioned in this region include:

Key Countries – United States, Canada

Largest Revenue Generating Country: United States

Base Year: 2023 :: Study Period: 2020-2032 :: Projection Years: 2024-2032

The United States captures the major share, accounting for $1439.47 million in 2023

The government is actively supporting innovation in artificial blood vessels through partnerships and funding for bioengineering research.
As per industry sources, DARPA (Defense Advanced Research Projects Agency) has provided around $46.4 million in funding for developing shelf-stable artificial blood products that can save lives in trauma settings, especially for soldiers and trauma victims.
Research institutions such as Harvard University are making strides in creating biomimetic artificial blood vessels using 3D printing. These vessels mimic the multilayer structure of human blood vessels, improving compatibility and durability.

Market Forecast for Canada

In terms of government initiatives, Canada has been active in fostering innovation within the biotechnology and medical device sectors. This includes support for research and development through funding programs like the Canadian Institutes of Health Research (CIHR), which provides grants for medical advancements. Additionally, partnerships between public health agencies and private biotech firms are essential in pushing the boundaries of artificial vascular technologies. These collaborations are aimed at improving healthcare outcomes and reducing reliance on organ donors by providing viable synthetic alternatives for critical surgeries.

The market is widely branched into type, patient demographic, application, end-user, and blood vessel diameter. The end-user section is divided into hospital, ambulatory surgical center, specialty clinic, and other end-users.

Specialty clinics use artificial blood vessels in procedures like vascular bypass surgery to restore blood flow to the heart, brain, or limbs. These vessels are also used to provide vascular access for patients undergoing dialysis for kidney disease. In cases of traumatic injuries or congenital blood vessel abnormalities, clinics may rely on artificial vessels to repair or replace damaged or malformed ones.

Contender Analysis in the Artificial Blood Vessels Market:

Becton, Dickinson and Company (BD) is a global leader in medical technology, specializing in the design, manufacture, and distribution of medical devices, laboratory equipment, and diagnostic tools. Serving healthcare providers and institutions around the world, BD’s products play a crucial role in patient care and medical research. The company is headquartered in New Jersey, the United States.

Other major companies in the market include WL Gore and Associates Inc, Vascular Graft Solutions, Getinge AB, and Roumai Medical.

KEY DELIVERABLES OF THE REPORT:

Market CAGR during the forecasting years 2024-2032
Detailed data highlighting key insights, industry components, and market strategies
Comprehensive information and estimation of the artificial blood vessels market revenue growth in North America and its influence on the parent market
In-depth study of forthcoming trends in consumer behavioral patterns
A meticulous analysis of the competitive landscape and Porter’s Five Forces
A wide-ranging study of factors that will challenge the NA artificial blood vessels market’s growth during the upcoming years

Want to get specific insights? Our team of analysts can customize this report based on your preferences. Connect with us here.

Major Players in the Market

Related Reports

Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT

Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT

Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC ALZHEIMER’S DISEASE THERAPEUTICS AND DIAGNOSTICS MARKET 2022-2028

Market by Therapeutics, Diagno ..

VIEW REPORT

Lifesciences

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

Market by Type, Application, E ..

VIEW REPORT

Table of Content

1. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – SUMMARY

2. INDUSTRY OUTLOOK

2.1. PORTER’S FIVE FORCES ANALYSIS

2.1.1. THREAT OF NEW ENTRANTS

2.1.2. THREAT OF SUBSTITUTES

2.1.3. BARGAINING POWER OF BUYERS

2.1.4. BARGAINING POWER OF SUPPLIERS

2.1.5. THREAT OF COMPETITIVE RIVALRY

2.2. MARKET MATURITY ANALYSIS

2.3. SUPPLY CHAIN ANALYSIS

2.3.1. RAW MATERIALS

2.3.2. MANUFACTURERS

2.3.3. DISTRIBUTORS

2.3.4. END-USER

2.4. REGULATORY FRAMEWORK

2.5. KEY BUYING IMPACT ANALYSIS

2.5.1. BIOCOMPATIBILITY

2.5.2. DURABILITY AND LONGEVITY

2.5.3. CUSTOMIZATION AND VERSATILITY

2.5.4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE

2.6. KEY MARKET STRATEGIES

2.6.1. COLLABORATIONS

2.6.2. PRODUCT LAUNCHES

2.6.3. ACQUISITIONS

2.6.4. BUSINESS DIVESTITURES & EXPANSIONS

2.7. MARKET DRIVERS

2.7.1. RISING RATES OF CARDIOVASCULAR DISEASES AND VASCULAR DISORDERS

2.7.2. DEVELOPMENTS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE

2.7.3. AGING POPULATION AND SHIFTING LIFESTYLES

2.8. MARKET CHALLENGES

2.8.1. EXPENSES IN THE DEVELOPMENT AND COMMERCIALIZATION OF ARTIFICIAL BLOOD VESSELS

2.8.2. STRICT REGULATORY APPROVALS AND CLINICAL TRIAL REQUIREMENTS

2.8.3. CHALLENGES RELATED TO BIOCOMPATIBILITY AND LONG-TERM DURABILITY

2.9. MARKET OPPORTUNITIES

2.9.1. ADVANCEMENTS IN 3D BIOPRINTING FOR TAILORED VASCULAR GRAFTS

2.9.2. USE OF NANOTECHNOLOGY AND BIOMIMETIC MATERIALS TO ENHANCE FUNCTIONALITY

2.10. ANALYST PERSPECTIVE

3. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – BY TYPE

3.1. EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE)

3.2. POLYETHYLENE TEREPHTHALATE (PET)

3.3. POLYURETHANE

3.4. OTHER TYPES

4. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – BY BLOOD VESSEL DIAMETER

4.1. LARGE

4.2. MEDIUM

4.3. SMALL

5. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – BY PATIENT DEMOGRAPHIC

5.1. PEDIATRIC

5.2. ADULT

6. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – BY APPLICATION

6.1. PERIPHERAL ARTERY

6.2. HEMODIALYSIS

6.3. AORTIC DISEASE

7. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – BY END-USER

7.1. HOSPITAL

7.2. SPECIALTY CLINIC

7.3. AMBULATORY SURGICAL CENTER

7.4. OTHER END-USERS

8. NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET – BY COUNTRY OUTLOOK

8.1. NORTH AMERICA

8.1.1. UNITED STATES

8.1.1.1. UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET FORECAST & PROSPECTS

8.1.2. CANADA

8.1.2.1. CANADA ARTIFICIAL BLOOD VESSELS MARKET FORECAST & PROSPECTS

9. COMPETITIVE LANDSCAPE

9.1. BECTON, DICKINSON AND COMPANY

9.1.1. OVERVIEW

9.1.2. PORTFOLIO

9.1.3. KEY STRENGTHS

9.1.4. KEY CHALLENGE

9.2. LEMAITRE VASCULAR INC

9.2.1. OVERVIEW

9.2.2. PORTFOLIO

9.2.3. KEY STRENGTHS

9.2.4. KEY CHALLENGE

9.3. MEDTRONIC PLC

9.3.1. OVERVIEW

9.3.2. PORTFOLIO

9.3.3. KEY STRENGTH

9.3.4. KEY CHALLENGE

9.4. TERUMO MEDICAL CORPORATION

9.4.1. OVERVIEW

9.4.2. PORTFOLIO

9.4.3. KEY STRENGTHS

9.4.4. KEY CHALLENGE

9.5. W. L. GORE AND ASSOCIATES INC

9.5.1. OVERVIEW

9.5.2. PORTFOLIO

9.5.3. KEY STRENGTHS

9.5.4. KEY CHALLENGES

9.6. GETINGE AB

9.6.1. OVERVIEW

9.6.2. PORTFOLIO

9.6.3. KEY STRENGTHS

9.6.4. KEY CHALLENGE

9.7. ROUMAI MEDICAL

9.7.1. OVERVIEW

9.7.2. PORTFOLIO

9.7.3. KEY STRENGTHS

9.7.4. KEY CHALLENGES

9.8. MEDICALEXPO

9.8.1. OVERVIEW

9.8.2. PORTFOLIO

9.8.3. KEY STRENGTHS

9.8.4. KEY CHALLENGES

9.9. VASCULAR GRAFT SOLUTIONS

9.9.1. OVERVIEW

9.9.2. PORTFOLIO

9.9.3. KEY STRENGTHS

9.9.4. KEY CHALLENGES

9.10. JIANGSU BIODA LIFE SCIENCE CO LTD

9.10.1. OVERVIEW

9.10.2. PORTFOLIO

9.10.3. KEY STRENGTHS

9.10.4. KEY CHALLENGE

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.2. SOURCES OF DATA

10.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)

TABLE 2: REGULATORY FRAMEWORK

TABLE 3: LIST OF COLLABORATIONS

TABLE 4: LIST OF PRODUCT LAUNCHES

TABLE 5: LIST OF ACQUISITIONS

TABLE 6: LIST OF BUSINESS DIVESTITURES & EXPANSIONS

TABLE 7: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, 2024-2032 (IN $ MILLION)

TABLE 8: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, 2024-2032 (IN $ MILLION)

TABLE 9: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, 2024-2032 (IN $ MILLION)

TABLE 10: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)

TABLE 11: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, 2024-2032 (IN $ MILLION)

TABLE 12: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)

List of Figures

FIGURE 1: MARKET MATURITY ANALYSIS

FIGURE 2: SUPPLY CHAIN ANALYSIS

FIGURE 3: KEY BUYING IMPACT ANALYSIS

FIGURE 4: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, 2023 & 2032 (IN %)

FIGURE 5: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE), 2024-2032 (IN $ MILLION)

FIGURE 6: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY POLYETHYLENE TEREPHTHALATE (PET), 2024-2032 (IN $ MILLION)

FIGURE 7: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY POLYURETHANE, 2024-2032 (IN $ MILLION)

FIGURE 8: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)

FIGURE 9: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, 2023 & 2032 (IN %)

FIGURE 10: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY LARGE, 2024-2032 (IN $ MILLION)

FIGURE 11: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY MEDIUM, 2024-2032 (IN $ MILLION)

FIGURE 12: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY SMALL, 2024-2032 (IN $ MILLION)

FIGURE 13: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHIC, 2023 & 2032 (IN %)

FIGURE 14: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PEDIATRIC, 2024-2032 (IN $ MILLION)

FIGURE 15: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY ADULT, 2024-2032 (IN $ MILLION)

FIGURE 16: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, 2023 & 2032 (IN %)

FIGURE 17: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY PERIPHERAL ARTERY, 2024-2032 (IN $ MILLION)

FIGURE 18: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY HEMODIALYSIS, 2024-2032 (IN $ MILLION)

FIGURE 19: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY AORTIC DISEASE, 2024-2032 (IN $ MILLION)

FIGURE 20: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, 2023 & 2032 (IN %)

FIGURE 21: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY HOSPITAL, 2024-2032 (IN $ MILLION)

FIGURE 22: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY SPECIALTY CLINIC, 2024-2032 (IN $ MILLION)

FIGURE 23: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY ONLINE PHARMACY, 2024-2032 (IN $ MILLION)

FIGURE 24: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER END-USER, 2024-2032 (IN $ MILLION)

FIGURE 25: NORTH AMERICA ARTIFICIAL BLOOD VESSELS MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)

FIGURE 26: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $ MILLION)

FIGURE 27: CANADA ARTIFICIAL BLOOD VESSELS MARKET 2024-2032 (IN $ MILLION)